169 related articles for article (PubMed ID: 29720672)
1. FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.
Garner EF; Williams AP; Stafman LL; Aye JM; Mroczek-Musulman E; Moore BP; Stewart JE; Friedman GK; Beierle EA
Sci Rep; 2018 May; 8(1):6913. PubMed ID: 29720672
[TBL] [Abstract][Full Text] [Related]
2. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
[TBL] [Abstract][Full Text] [Related]
3. FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model.
Szymiczek A; Pastorino S; Larson D; Tanji M; Pellegrini L; Xue J; Li S; Giorgi C; Pinton P; Takinishi Y; Pass HI; Furuya H; Gaudino G; Napolitano A; Carbone M; Yang H
J Transl Med; 2017 Mar; 15(1):58. PubMed ID: 28298211
[TBL] [Abstract][Full Text] [Related]
4. PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
Stafman LL; Williams AP; Marayati R; Aye JM; Stewart JE; Mroczek-Musulman E; Beierle EA
PLoS One; 2019; 14(4):e0214469. PubMed ID: 30969990
[TBL] [Abstract][Full Text] [Related]
5. Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.
Williams AP; Garner EF; Waters AM; Stafman LL; Aye JM; Markert H; Stewart JE; Beierle EA
Transl Oncol; 2019 Jan; 12(1):84-95. PubMed ID: 30286326
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells.
Perla AS; Fratini L; Cardoso PS; de Farias CB; da Cunha Jaeger M; Roesler R
Pediatr Hematol Oncol; 2020 Mar; 37(2):170-175. PubMed ID: 31826690
[TBL] [Abstract][Full Text] [Related]
7. Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma.
Huq S; Kannapadi NV; Casaos J; Lott T; Felder R; Serra R; Gorelick NL; Ruiz-Cardozo MA; Ding AS; Cecia A; Medikonda R; Ehresman J; Brem H; Skuli N; Tyler BM
J Neurosurg Pediatr; 2021 Feb; 27(4):482-488. PubMed ID: 33545678
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of FTY720 (Fingolimod) Derivatives with Aromatic Head Group as Anticancer Agents.
Lee T; Moon HS; Kim SW; Shrestha J; Shin SM; Lee JY; Kim S; Park EY; Baek DJ
Chem Pharm Bull (Tokyo); 2018; 66(10):1015-1018. PubMed ID: 30270236
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
[TBL] [Abstract][Full Text] [Related]
10. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
11. Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Cristóbal I; Madoz-Gúrpide J; Manso R; González-Alonso P; Rojo F; García-Foncillas J
Curr Med Res Opin; 2016 Jun; 32(6):1137-41. PubMed ID: 26950691
[TBL] [Abstract][Full Text] [Related]
12. FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
Kreitzburg KM; Fehling SC; Landen CN; Gamblin TL; Vance RB; Arend RC; Katre AA; Oliver PG; van Waardenburg RCAM; Alvarez RD; Yoon KJ
Cancer Lett; 2018 Nov; 436():75-86. PubMed ID: 30120964
[TBL] [Abstract][Full Text] [Related]
13. A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
Vicente C; Arriazu E; Martínez-Balsalobre E; Peris I; Marcotegui N; García-Ramírez P; Pippa R; Rabal O; Oyarzábal J; Guruceaga E; Prósper F; Mateos MC; Cayuela ML; Odero MD
Cancer Lett; 2020 Jan; 468():1-13. PubMed ID: 31593801
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
Martin JL; Julovi SM; Lin MZ; de Silva HC; Boyle FM; Baxter RC
Breast Cancer Res; 2017 Aug; 19(1):90. PubMed ID: 28778177
[TBL] [Abstract][Full Text] [Related]
15. FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
Li J; Wang SW; Zhang DS; Sun Y; Zhu CY; Fei Q; Hu J; Zhang C; Sun YM
Oncol Rep; 2016 May; 35(5):2833-42. PubMed ID: 26985637
[TBL] [Abstract][Full Text] [Related]
16. Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma.
Goto RN; Sobral LM; Stringhetta-Padovani K; Garcia CB; da Silva G; Vitek MP; Leopoldino AM
Eur J Pharmacol; 2020 Sep; 882():173268. PubMed ID: 32569675
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models.
Cook Sangar ML; Genovesi LA; Nakamoto MW; Davis MJ; Knobluagh SE; Ji P; Millar A; Wainwright BJ; Olson JM
Clin Cancer Res; 2017 Oct; 23(19):5802-5813. PubMed ID: 28637687
[No Abstract] [Full Text] [Related]
18. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
[TBL] [Abstract][Full Text] [Related]
19. Icariin induces S-phase arrest and apoptosis in medulloblastoma cells.
Sun Y; Sun XH; Fan WJ; Jiang XM; Li AW
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(4):123-9. PubMed ID: 27188746
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
